MRI data and genomic data are telling us different things about prostate cancer risk

A new paper just published on line in the journal PLoS One is entitled, “Association between a 17-gene genomic prostate score and a multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)”. … READ MORE …

Old and newer tests and risks for prostate cancer; can you avoid inappropriate biopsy?

We now have five approved tests that can (at least in theory) help a man — and his doctors — to decide whether he is at sufficient risk for clinically significant prostate cancer that he should go get a biopsy. But how good are they really? … READ MORE …

Mapping biopsies vs mpMRI vs Prostate Histoscanning technology

According to a recently published article, European researchers are initiating a new study to explore the ability of multi-parametic MRIs (mpMRI) and the Prostate HistoScanning™ (PHS) technique to rule out risk for clinically significant prostate cancer. … READ MORE …